Literature DB >> 2714131

5-Aminosalicylic acid suppositories in the management of ulcerative colitis.

M Campieri1, P Gionchetti, A Belluzzi, C Brignola, F Torresan, M Tampieri, P Iannone, M Miglioli, L Barbara.   

Abstract

5-aminosalicylic acid (5-ASA) suppositories have been used in the author's out-patient clinic in Bologna for the treatment of distal ulcerative colitis (UC). One hundred fifty-six patients with mild or moderate attacks of UC were treated using different protocols for controlling active disease. Improvement was observed in 88.5 percent of the therapeutic cycles after one month. A small preliminary maintenance study using only 400-mg suppositories of 5-ASA twice a day for 6 or 12 months showed a remission percentage similar to salicylazosulfapyridine (SASP).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2714131     DOI: 10.1007/BF02563691

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

Review 1.  New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.

Authors:  M Campieri
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial.

Authors:  M Campieri; P Gionchetti; A Belluzzi; C Brignola; M Tampieri; P Iannone; G Brunetti; M Miglioli; L Barbara
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.